Impact of body mass index on survival in women receiving chemotherapy for early breast cancer.

Rossanna C PezoKelvin K W ChanDanilo Giffoni M M MataInes MenjakAndrea EisenMaureen Trudeau

Published in: Breast cancer research and treatment (2022)

Our large population-based retrospective cohort analysis of EBC patients receiving adjuvant anthracycline-taxane chemotherapy found no significant impact of BMI on OS. Further investigation is warranted to confirm these findings in prospective patient cohorts.

Keyphrases

body mass index
early breast cancer
locally advanced
weight gain
early stage
polycystic ovary syndrome
case report
physical activity
cross sectional
squamous cell carcinoma
rectal cancer
pregnancy outcomes
type diabetes
chemotherapy induced
radiation therapy
pregnant women
free survival